Position in MDCX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$0
-$18,561 QoQ
Shares Held
2,203
-94.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDCX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS Group AG holds $17,056,271,930 across 20 Drug Manufacturers - General names. MDCX ranks #20 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,865,931 | $4,636,914,000 | |
| 2 | ABBV |
AbbVie Inc.
|
12,845,120 | $3,232,345,993 | |
| 3 | JNJ |
Johnson & Johnson
|
11,036,891 | $2,803,039,201 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,744,783 | $1,766,204,613 | |
| 5 | AMGN |
Amgen Inc
|
3,308,695 | $1,198,144,628 | |
| 6 | AZN |
Astrazeneca PLC
|
5,297,462 | $1,004,504,738 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,503,294 | $568,946,162 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,876,439 | $511,460,413 |
All Filings in MDCX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 MDCXW | — | 2,203 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 MDCXW | — | 1,465 | Shares | Defined | 2026-05-05 | |
| 2026-03-31 | $18,561 | 40,441 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $20,242 | 13,231 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $16,105 | 6,957 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $92,468 | 30,926 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 MDCXW | — | 2,299 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $79,094 | 21,262 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 MDCXW | — | 2,000 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||